Cross-drug resistance to sunitinib induced by doxorubicin in endothelial cells.

about

Cross-drug resistance to sunitinib induced by doxorubicin in endothelial cells.

Item

http://www.wikidata.org/entity/Q41921173

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Cross-drug resistance to sunitinib induced by doxorubicin in endothelial cells.

@en

type

Item

label

Cross-drug resistance to sunitinib induced by doxorubicin in endothelial cells.

@en

prefLabel

Cross-drug resistance to sunitinib induced by doxorubicin in endothelial cells.

@en

P1476

Cross-drug resistance to sunitinib induced by doxorubicin in endothelial cells.

@en

P2093

Anne Janin

http://www.w3.org/2001/XMLSchema#string

Chaoquan Hu

http://www.w3.org/2001/XMLSchema#string

Hong Li

http://www.w3.org/2001/XMLSchema#string

Jean-Pierre Vannier

http://www.w3.org/2001/XMLSchema#string

Jian Jin

http://www.w3.org/2001/XMLSchema#string

Jielin Liu

http://www.w3.org/2001/XMLSchema#string

Li Wang

http://www.w3.org/2001/XMLSchema#string

Limin Huang

http://www.w3.org/2001/XMLSchema#string

Rémi Varin

http://www.w3.org/2001/XMLSchema#string

P2860

Mechanisms of tumor resistance to small-molecule vascular disrupting agents: treatment and rationale of combination therapy

Tumor angiogenesis: therapeutic implications

Microenvironmental regulation of tumor progression and metastasis

Angiogenesis as a therapeutic target

Impact of genetic variation in breast cancer resistance protein (BCRP/ABCG2) on sunitinib pharmacokinetics.

Localisation of breast cancer resistance protein in microvessel endothelium of human brain.

Structure and function of the human breast cancer resistance protein (BCRP/ABCG2).

Evidence of antiangiogenic and antimetastatic activities of the recombinant disintegrin domain of metargidin.

Effect of the breast-cancer resistance protein on atypical multidrug resistance.

Inhibition of tumor angiogenesis as a strategy to circumvent acquired resistance to anti-cancer therapeutic agents.

P304

1287-1292

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/OL.2014.2819

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

He Lu

Mélanie Di Benedetto

P577

2014-12-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

272097540

http://www.w3.org/2001/XMLSchema#string

P698

25663899

http://www.w3.org/2001/XMLSchema#string

P932

4315062

http://www.w3.org/2001/XMLSchema#string